EP. 3 Treatment Selection in Metastatic and Castration Resistant Prostate Cancer: Optimizing Outcomes and Preserving Patient Quality of Life
EP. 5 Targeting the Androgen Receptor Pathway and Overcoming Treatment Resistance in Advanced Prostate Cancer
EP. 6 Emerging AR Targeting Agents and CDK4/6 Inhibitors in Metastatic Prostate Cancer and Potential Impact on the Treatment Landscape
EP. 7 Multidisciplinary Collaboration and Expert Insights in the Management of Advanced Prostate Cancer
Interpreting real-world evidence in ARPI treatment decisions, with Martin Schoen, MD, PhDByMartin Schoen, MD, PhD,Hannah ClarkeSeptember 10th 2026
App-based intervention aims to increase PSA screening among Black menByHannah ClarkeSeptember 9th 2026
The critical role of advocacy in urologic oncologyByRuchika Talwar, MD,Lan Anh Galloway, MDSeptember 9th 2026
Higher saturated fat intake associated with increased mortality in nonmetastatic prostate cancerByHannah ClarkeSeptember 7th 2026